Anticoagulant pretreatment attenuates production of cytokine-induced neutrophil chemoattractant following ischemia-reperfusion of rat liver

Digestive Diseases and Sciences

Volumn 41, Issue 7, 1996, Pages 1481-1486

  Hisama, Naoya ^b   Yamaguchi, Yasuo ^b   Okajima, Kenji ^b   Uchiba, Mitsuhiro ^b   Murakami, Kazunori ^b   Mori, Katsutaka ^b   Yamada, Shinwa ^b   Ogawa, Michio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

coagulation; cytokine induced neutrophil chemoattractant; ischemia reperfusion injury; liver; rat

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBIN III; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; HEPARIN; KETONE DERIVATIVE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; LIVER ISCHEMIA; MALE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTICOAGULANTS; ANTITHROMBIN III; ANTITHROMBINS; BLOTTING, NORTHERN; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; FACTOR XA; GROWTH INHIBITORS; GROWTH SUBSTANCES; HEPARIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; NEUTROPHILS; PEROXIDASE; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER;

EID: 0030057238     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02088576     Document Type: Article

References (36)

1. Welbourn R, Golman G, O'Riordan M, Lindsay TF, Paterson IS, Kobzik L, Valeri CR, Shepro D, Hechtman MB: Role of tumor necrosis factor as mediator of lung injury following torso ischemia. J Appl Physiol 70:2645-2649, 1991
2. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SJ: Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia/reperfusion injury. Ann Surg 212:694-700, 1990
3. Mangino MJ, Anderson CB, Murphy MK, Brunt E, Turk J: Mucosal arachidonate metabolism and intestinal ischemia/ reperfusion injury. Am J Physiol 257:G299-G307, 1989
4. Mozes T, Braquet P, Filep J: Platelet-activating factor: An endogenous mediator of mesenteric ischemia/reperfusion-induced shock. Am J Physiol 257:R872-R877, 1989
5. Wetlin WF, Gimborne MA Jr: Neutrophil-mediated damage to human vascular endothelium. Am J Pathol 142:117-128, 1993
6. Varani J, Ginsburg I, Schuger L, Gibbs DF, Bromberg J, Johnson KJ, Ryan US, Ward PA: Endothelial killing by neutrophils. Am J Pathol 135:435-438, 1989
7. Carlos TM, Harlan JM: Leukocyte-endothelial adhesion molecules. Blood 84:2068-2101, 1994
8. Campbell EJ, Senior RM, McDonald JA, Cox DL: Proteolysis by neutrophils. J Clin Invest 70:845-852, 1982
9. Fajarado LF: The complexity of endothelial cells. Am J Clin Pathol 92:241-250, 1989
10. Rosenberg RD, Rosenberg JS: Natural anticoagulant mechanisms. J Clin Invest 74:1-6, 1984
11. Esmon CT, Esmon NL, Harris KW: Complex formation between thrombin and thrombomodulin inhibits both thrombin catalyzed fibrin formation and factor V activation. J Biol Chem 257:7944-7977, 1982
12. Watanabe K, Suematsu M, Iida M, Takaishi K, Iizuka Y, Suzuki H, Suzuki M, Tsuchiya M, Tsurufuji S: Effect of rat CINC/gro, a member of interleukin-8 family, on leukocytes in microcirculation of the rat mesentery. Exp Mol Pathol 56:60-69, 1992
13. Watanabe K, Kinoshita S, Nakagawa H: Purification and characterization of cytokine-induced neutrophil chemoattractant produced by epithelial cell line of normal rat kidney (NRK-52E cell). Biochem Biophys Res Commun 161:1093-1099, 1989
14. National Institutes of Health: Guide for the care and use of laboratory animals. Public Health Service, NIH Publication No. 86-23, Bethesda, Maryland, 1985
15. Kettner C, Shaw E: The selective affinity labeling of factor Xa by peptides of arginine chloromethyl ketone. Thromb Res 22:645-651, 1981
16. Nakagawa H, Ikesue A, Kato H, Debuchi H, Watanabe K, Turufuji S, Naganawa M, Mitamura M: Changes in the levels of rat interleukin 8/CINC and gelatinase in the exudate of carrageenin-induced inflammation in rats. J Pharmacobiodyn 15:461-466, 1992
17. Chromczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1962
18. Warren JS, Yabroff KR, Remick DG, Kunkel SL, Chensue SW, Kunkel RG, Johnson KJ, Ward PA: Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest 84:1873-1882, 1989
19. Henson PM, Zanolari MB, Schwarzman NA, Hong SR: Intracellular control of human neutrophil secretion: I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B. J Immunol 121:851-855, 1978
20. Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol 55:283-290, 1971
21. Ghezzi P, Dinarello CA, Bianchi M, Rosandich ME, Repine JE, White CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 3:189-194, 1991
22. Koga S, Ogawa S, Kuwahara K, Brett J, Leavy JA, Ryan J, Koga Y, Plocinski J, Benjamin W, Burns DK, Stern D: Synthesis and release of interleukin 1 by reoxygenated human mononuclear phagocytes. J Clin Invest 90:1007-1015, 1992
23. Jones A, Geczy CL: Thrombin and factor Xa enhances the production of interleukin-1. Immunology 71:236-241, 1990
24. Robinson SC, Shephard EG, Kirsch RE: Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1β. IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322-326, 1994
25. Wachtfogel YT, Pixley RA, Kucich U, Abrams W, Weinbaum G, Schapira M, Colman RW: Purified plasma factor XIIa aggregates human neutrophils and causes degranulation. Blood 67:1731-1737, 1986
26. Wachtfogel YT, Kucich U, James HL, Scott CF, Schapira M, Zimmerman M, Cohen AB, Colman RW: Human plasma kallikrein release neutrophil elastase during blood coagulation. J Clin Invest 72:1672-1677, 1983
27. Colman RW: Interactions between the contact system, neutrophils and fibrinogen. Adv Exp Med Biol 281:105-120, 1990
28. Cooper JA, Solano SJ, Bizios R, Kaplan JE, Malik AB: Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J Appl Physiol 57:826-832, 1984
29. Kirchhofer D, Sakariassen KS, Clozel M, Tschopp TB, Hadvary P, Nemerson Y, Baumgartner HR: Relationship between tissue factor expression and deposition of fibrin, platelets, and leukocytes on cultured endothelial cells under venous blood flow conditions. Blood 81:2050-2058, 1993
30. Loike JD, Silverstein R, Wright SD, Weitz JI, Huang AJ, Silverstein SC: The role of protected extracellular compartments in interactions between leukocytes, platelets, and fibrin/ fibrinogen matrices. Ann NY Acad Sci 667:163-172, 1992
31. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B: Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selection on adherent platelets. Nature 359:848-851, 1992
32. Fernadez HN, Henson PM, Otani A, Hugh TE: Chemotactic esponses to human C3a and C5a anaphylatoxins: I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions. J Immunol 120:109-115, 1978
33. Schiffmann E, Corcoran BA, Wahl SM: N-Formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sci USA 72:1059-1062, 1975
34. Ford-Hutchinson AW, Bray MA, Doig MV, Shipley ME, Smith MJ: Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286:264-265, 1980
35. Showell HJ, Freer RJ, Zigmoid SH, Schiffmann E, Aswanikumar S, Corcoran B, Becker EL: The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal secretion for neutrophils. J Exp Med 143:1154-1169, 1976
36. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide- 1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989